Inflammation and neuropeptides: the connection in diabetic wound healing

Leena Pradhan; Christoph Nabzdyk; Nicholas D. Andersen; Frank W. LoGerfo; Aristidis Veves

doi:10.1017/S1462399409000945

Inflammation and neuropeptides: the connection in diabetic wound healing

Published online by Cambridge University Press: 13 January 2009

Leena Pradhan ,

Christoph Nabzdyk ,

Nicholas D. Andersen ,

Frank W. LoGerfo and

Aristidis Veves

Show author details

Leena Pradhan: Affiliation:
Department of Surgery, Division of Vascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Christoph Nabzdyk: Affiliation:
Charité University Medicine, Joined Medical Faculty of Free University and Humboldt University, Berlin, Germany.
Nicholas D. Andersen: Affiliation:
Department of Surgery, Division of Vascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Frank W. LoGerfo: Affiliation:
Department of Surgery, Division of Vascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Aristidis Veves*: Affiliation:
Department of Surgery, Microcirculation Laboratory, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
*: *Corresponding author: Aristidis Veves, Microcirculation Laboratory, Beth Israel Deaconess Medical Center, Palmer 317, West Campus, One Deaconess Rd, Boston, MA 02215, USA. Tel: +1 617 632 7075; Fax: +1 617 632 0860; E-mail: [email protected]

Article contents

Abstract
References

Get access

Rights & Permissions

Abstract

Abnormal wound healing is a major complication of both type 1 and type 2 diabetes, with nonhealing foot ulcerations leading in the worst cases to lower-limb amputation. Wound healing requires the integration of complex cellular and molecular events in successive phases of inflammation, cell proliferation, cell migration, angiogenesis and re-epithelialisation. A link between wound healing and the nervous system is clinically apparent as peripheral neuropathy is reported in 30–50% of diabetic patients and is the most common and sensitive predictor of foot ulceration. Indeed, a bidirectional connection between the nervous and the immune systems and its role in wound repair has emerged as one of the focal features of the wound-healing dogma. This review provides a broad overview of the mediators of this connection, which include neuropeptides and cytokines released from nerve fibres, immune cells and cutaneous cells. In-depth understanding of the signalling pathways in the neuroimmune axis in diabetic wound healing is vital to the development of successful wound-healing therapies.

Type: Review Article
Information: Expert Reviews in Molecular Medicine , Volume 11 , July 2009 , e2

DOI: https://doi.org/10.1017/S1462399409000945 [Opens in a new window]
Copyright: Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1[No authors listed] (2008) Economic costs of diabetes in the U.S. in 2007. Diabetes Care 31, 596-615CrossRef Google Scholar

2[No authors listed] (1999) Consensus Development Conference on Diabetic Foot Wound Care: 7–8 April 1999, Boston, Massachusetts. American Diabetes Association. Diabetes Care 22, 1354-1360Google Scholar

3Boulton, A.J. et al. (2005) The global burden of diabetic foot disease. Lancet 366, 1719-1724CrossRef Google Scholar PubMed

4Edmonds, M.E. et al. (1986) Improved survival of the diabetic foot: the role of a specialized foot clinic. QJM 60, 763-771Google Scholar PubMed

5Thomson, F. et al. (1991) A team approach to diabtic foot care–the Manchester experience. The Foot 1, 75-82CrossRef Google Scholar

6Falanga, V. (2005) Wound healing and its impairment in the diabetic foot. Lancet 366, 1736-1743CrossRef Google Scholar PubMed

7Bagdade, J.D., Root, R.K. and Bulger, R.J. (1974) Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 23, 9-15CrossRef Google Scholar PubMed

8Nolan, C.M., Beaty, H.N. and Bagdade, J.D. (1978) Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes. Diabetes 27, 889-894CrossRef Google Scholar PubMed

9Falanga, V. (1993) Chronic wounds: pathophysiologic and experimental considerations. Journal of Investigative Dermatology 100, 721-725CrossRef Google Scholar PubMed

10Claudy, A.L. et al. (1991) Detection of undegraded fibrin and tumor necrosis factor-alpha in venous leg ulcers. Journal of the American Academy of Dermatology 25, 623-627CrossRef Google Scholar PubMed

11Loots, M.A. et al. (1998) Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. Journal of Investigative Dermatology 111, 850-857CrossRef Google Scholar PubMed

12Rosner, K. et al. (1995) Immunohistochemical characterization of the cutaneous cellular infiltrate in different areas of chronic leg ulcers. APMIS 103, 293-299CrossRef Google Scholar PubMed

13Moore, K., Ruge, F. and Harding, K.G. (1997) T lymphocytes and the lack of activated macrophages in wound margin biopsies from chronic leg ulcers. British Journal of Dermatology 137, 188-194CrossRef Google Scholar PubMed

14Herrick, S.E. et al. (1992) Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. American Journal of Pathology 141, 1085-1095Google Scholar PubMed

15Duraisamy, Y. et al. (2001) Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: possible relevance to wound healing in diabetes. Angiogenesis 4, 277-288CrossRef Google Scholar PubMed

16Elenkov, I.J. (2008) Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochemistry International 52, 40-51CrossRef Google Scholar PubMed

17Engelhardt, E. et al. (1998) Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. American Journal of Pathology 153, 1849-1860CrossRef Google Scholar PubMed

18Hebda, P.A., Collins, M.A. and Tharp, M.D. (1993) Mast cell and myofibroblast in wound healing. Dermatologic Clinics 11, 685-696CrossRef Google Scholar PubMed

19Trautmann, A. et al. (2000) Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo. Journal of Pathology 190, 100-1063.0.CO;2-Q>CrossRef Google Scholar PubMed

20Riches, D.W.H. (1996) Macrophage involvement in wound repair, remodeling and fibrosis. In The Molecular and Cellular Biology of Wound Repair (Clark, R.A.F., ed.), pp. 95-141, Plenum Press, New York, USAGoogle Scholar

21Sunderkotter, C. et al. (1994) Macrophages and angiogenesis. Journal of Leukocyte Biology 55, 410-422CrossRef Google Scholar PubMed

22Guest, C.B. et al. (2008) The implication of proinflammatory cytokines in type 2 diabetes. Frontiers in Bioscience 13, 5187-5194CrossRef Google Scholar PubMed

23Hildebrand, F., Pape, H.C. and Krettek, C. (2005) [The importance of cytokines in the posttraumatic inflammatory reaction.] Unfallchirurg 108, 793-794, 796–803 [Article in German]CrossRef Google Scholar PubMed

24Belperio, J.A. et al. (2000) CXC chemokines in angiogenesis. Journal of Leukocyte Biology 68, 1-8CrossRef Google Scholar PubMed

25Tilg, H. and Moschen, A.R. (2008) Inflammatory mechanisms in the regulation of insulin resistance. Molecular Medicine 14, 222-231CrossRef Google Scholar PubMed

26Bogdanski, P. et al. (2007) Influence of insulin therapy on expression of chemokine receptor CCR5 and selected inflammatory markers in patients with type 2 diabetes mellitus. International Journal of Clinical Pharmacology and Therapeutics 45, 563-567CrossRef Google Scholar

27Syrenicz, A. et al. (2006) Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents. Neuroendocrinolology Letters 27, 453-458Google Scholar PubMed

28Rosa, J.S. et al. (2008) Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus. Pediatric Diabetes 9, 9-16CrossRef Google Scholar PubMed

29Devaraj, S. et al. (2006) Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 55, 774-779CrossRef Google Scholar

30Dickinson, S. et al. (2008) High-glycemic index carbohydrate increases nuclear factor-kappaB activation in mononuclear cells of young, lean healthy subjects. American Journal of Clinical Nutrition 87, 1188-1193Google Scholar PubMed

31Kempf, K. et al. (2007) The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression. Journal of Molecular Medicine 85, 389-396CrossRef Google Scholar PubMed

32Fisman, E.Z., Adler, Y. and Tenenbaum, A. (2008) Biomarkers in cardiovascular diabetology: interleukins and matrixins. Advances in Cardiology 45, 44-64CrossRef Google Scholar PubMed

33Hatanaka, E. et al. (2006) Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clinical and Experimental Immunology 146, 443-447CrossRef Google Scholar PubMed

34Hand, W.L., Hand, D.L. and Vasquez, Y. (2007) Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes. Diabetes Research and Clinical Practice 76, 44-50CrossRef Google Scholar PubMed

35Stegenga, M.E. et al. (2008) Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabetic Medicine 25, 157-164CrossRef Google Scholar PubMed

36Alba-Loureiro, T.C. et al. (2006) Diabetes causes marked changes in function and metabolism of rat neutrophils. Journal of Endocrinology 188, 295-303CrossRef Google Scholar PubMed

37Mastej, K. and Adamiec, R. (2008) Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy. Acta Diabetologica 45, 183-190CrossRef Google Scholar PubMed

38Marhoffer, W. et al. (1993) Evidence of ex vivo and in vitro impaired neutrophil oxidative burst and phagocytic capacity in type 1 diabetes mellitus. Diabetes Research and Clinical Practice 19, 183-188CrossRef Google Scholar PubMed

39Alba-Loureiro, T.C. et al. (2007) Neutrophil function and metabolism in individuals with diabetes mellitus. Brazilian Journal of Medical and Biological Research 40, 1037-1044CrossRef Google Scholar PubMed

40Oncul, O. et al. (2007) Effect of the function of polymorphonuclear leukocytes and interleukin-1 beta on wound healing in patients with diabetic foot infections. Journal of Infection 54, 250-256CrossRef Google Scholar PubMed

41Ochoa, O., Torres, F.M. and Shireman, P.K. (2007) Chemokines and diabetic wound healing. Vascular 15, 350-355CrossRef Google Scholar PubMed

42Shanmugam, N., Ransohoff, R.M. and Natarajan, R. (2006) Interferon-gamma-inducible protein (IP)-10 mRNA stabilized by RNA-binding proteins in monocytes treated with S100b. Journal of Biological Chemistry 281, 31212-31221CrossRef Google Scholar PubMed

43Shanmugam, N. et al. (2008) Proinflammatory effects of advanced lipoxidation end products in monocytes. Diabetes 57, 879-888CrossRef Google Scholar PubMed

44Galkowska, H., Wojewodzka, U. and Olszewski, W.L. (2006) Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair and Regeneration 14, 558-565CrossRef Google Scholar PubMed

45Laine, P.S. et al. (2007) Palmitic acid induces IP-10 expression in human macrophages via NF-kappaB activation. Biochemical and Biophysical Research Communications 358, 150-155CrossRef Google Scholar PubMed

46Maulik, N. and Das, D.K. (2002) Redox signaling in vascular angiogenesis. Free Radical Biology and Medicine 33, 1047-1060CrossRef Google Scholar PubMed

47Soneja, A., Drews, M. and Malinski, T. (2005) Role of nitric oxide, nitroxidative and oxidative stress in wound healing. Pharmacological Reports 57 (Suppl), 108-119Google Scholar PubMed

48Lateef, H. et al. (2005) Pretreatment of diabetic rats with lipoic acid improves healing of subsequently-induced abrasion wounds. Archives of Dermatological Research 297, 75-83CrossRef Google Scholar PubMed

49Straino, S. et al. (2008) High-mobility group box 1 protein in human and murine skin: involvement in wound healing. Journal of Investigative Dermatology 128, 1545-1553CrossRef Google Scholar PubMed

50Corrales, J.J. et al. (2007) Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications. Journal of Diabetes and its Complications 21, 41-49CrossRef Google Scholar PubMed

51Maruyama, K. et al. (2007) Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. American Journal of Pathology 170, 1178-1191CrossRef Google Scholar PubMed

52Urbancic-Rovan, V. (2005) Causes of diabetic foot lesions. Lancet 366, 1675-1676CrossRef Google Scholar PubMed

53Sheehan, P. et al. (2003) Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 26, 1879-1882CrossRef Google Scholar

54Young, M.J., Breddy, J.L., Veves, A. and Boulton, A.J. (1994) The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 17, 557-560CrossRef Google Scholar PubMed

55Adler, A.I. et al. (1997) Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 20, 1162-1167CrossRef Google Scholar PubMed

56Reiber, G.E. et al. (1999) Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 22, 157-162CrossRef Google Scholar PubMed

57Yao, J.S. et al. (2006) Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9. Biochemical and Biophysical Research Communications 342, 1396-1404CrossRef Google Scholar PubMed

58Vinik, A.I. et al. (2000) Diabetic neuropathies. Diabetologia 43, 957-973CrossRef Google Scholar PubMed

59Lindberger, M. et al. (1989) Nerve fibre studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuropeptides in diabetes mellitus. Journal of the Neurological Sciences 93, 289-296CrossRef Google Scholar PubMed

60Galkowska, H. et al. (2006) Neurogenic factors in the impaired healing of diabetic foot ulcers. Journal of Surgical Research 134, 252-258CrossRef Google Scholar PubMed

61Quattrini, C., Jeziorska, M. and Malik, R.A. (2004) Small fiber neuropathy in diabetes: clinical consequence and assessment. The International Journal of Lower Extremity Wounds 3, 16-21CrossRef Google Scholar PubMed

62Luger, T.A. (2002) Neuromediators–a crucial component of the skin immune system. Journal of Dermatological Science 30, 87-93CrossRef Google Scholar PubMed

63Berczi, I. et al. (1996) The immune effects of neuropeptides. Baillieres Clinical Rheumatology 10, 227-257CrossRef Google Scholar PubMed

64Krishnan, S.T. et al. (2007) Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects. Diabetes Care 30, 3058-3062CrossRef Google Scholar PubMed

65Pomposelli, F.B. et al. (2003) A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. Journal of Vascular Surgery 37, 307-315CrossRef Google Scholar PubMed

66Vareniuk, I., Pavlov, I.A. and Obrosova, I.G. (2008) Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes. Diabetologia 51, 2126-2133CrossRef Google Scholar

67Obrosova, I.G. et al. (2005) Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 54, 3435-3441CrossRef Google Scholar PubMed

68Kellogg, A.P. et al. (2007) Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes 56, 2997-3005CrossRef Google Scholar PubMed

69Obrosova, I.G. et al. (2007) High-fat diet induced neuropathy of pre-diabetes and obesity: effects of “healthy” diet and aldose reductase inhibition. Diabetes 56, 2598-2608CrossRef Google Scholar PubMed

70Roosterman, D. et al. (2006) Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiological Reviews 86, 1309-1379CrossRef Google Scholar PubMed

71Nakamura, M. et al. (2003) Promotion of corneal epithelial wound healing in diabetic rats by the combination of a substance P-derived peptide (FGLM-NH2) and insulin-like growth factor-1. Diabetologia 46, 839-842CrossRef Google Scholar PubMed

72Movafagh, S. et al. (2006) Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. The FASEB Journal 20, 1924-1926CrossRef Google Scholar PubMed

73Ekstrand, A.J. et al. (2003) Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proceedings of the National Academy of Sciences of the United States of America 100, 6033-6038CrossRef Google Scholar PubMed

74Kuo, L.E., Abe, K. and Zukowska, Z. (2007) Stress, NPY and vascular remodeling: Implications for stress-related diseases. Peptides 28, 435-440CrossRef Google Scholar PubMed

75Delgado, A.V., McManus, A.T. and Chambers, J.P. (2005) Exogenous administration of Substance P enhances wound healing in a novel skin-injury model. Experimental Biology and Medicine 230, 271-280CrossRef Google Scholar

76Zukowska, Z., Grant, D.S. and Lee, E.W. (2003) Neuropeptide Y: a novel mechanism for ischemic angiogenesis. Trends in Cardiovascular Medicine 13, 86-92CrossRef Google Scholar PubMed

77Hokfelt, T. et al. (1975) Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Research 100, 235-252CrossRef Google Scholar PubMed

78Hokfelt, T. et al. (1975) Substance p: localization in the central nervous system and in some primary sensory neurons. Science 190, 889-890CrossRef Google Scholar PubMed

79Maggi, C.A. (2000) The troubled story of tachykinins and neurokinins. Trends in Pharmacological Sciences 21, 173-175CrossRef Google Scholar PubMed

80Maggi, C.A. (1995) The mammalian tachykinin receptors. General Pharmacology 26, 911-944CrossRef Google Scholar PubMed

81Khawaja, A.M. and Rogers, D.F. (1996) Tachykinins: receptor to effector. International Journal of Biochemistry and Cell Biology 28, 721-738CrossRef Google Scholar PubMed

82Harrison, S. and Geppetti, P. (2001) Substance P. International Journal of Biochemistry and Cell Biology 33, 555-576CrossRef Google Scholar PubMed

83Kunt, T. et al. (2000) Serum levels of substance P are decreased in patients with type 1 diabetes. Experimental and Clinical Endocrinology and Diabetes 108, 164-167CrossRef Google Scholar PubMed

84Olerud, J.E. et al. (1999) Neutral endopeptidase expression and distribution in human skin and wounds. Journal of Investigative Dermatology 112, 873-881CrossRef Google Scholar PubMed

85Bou-Gharios, G. et al. (1995) Expression of ectopeptidases in scleroderma. Annals of the Rheumatic Diseases 54, 111-116CrossRef Google Scholar PubMed

86Antezana, M. et al. (2002) Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers. Journal of Investigative Dermatology 119, 1400-1404CrossRef Google Scholar PubMed

87Spenny, M.L. et al. (2002) Neutral endopeptidase inhibition in diabetic wound repair. Wound Repair and Regeneration 10, 295-301CrossRef Google Scholar PubMed

88Pernow, B. (1983) Substance P. Pharmacological Reviews 35, 85-141Google Scholar PubMed

89Ho, W.Z. et al. (1997) Human monocytes and macrophages express substance P and neurokinin-1 receptor. Journal of Immunology 159, 5654-5660CrossRef Google Scholar PubMed

90Lai, J.P., Douglas, S.D. and Ho, W.Z. (1998) Human lymphocytes express substance P and its receptor. Journal of Neuroimmunology 86, 80-86CrossRef Google Scholar PubMed

91Lai, J.P. et al. (2002) Quantification of substance p mRNA in human immune cells by real-time reverse transcriptase PCR assay. Clinical and Diagnostic Laboratory Immunology 9, 138-143Google Scholar PubMed

92Lambrecht, B.N. (2001) Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation. Respiratory Research 2, 133-138CrossRef Google Scholar PubMed

93Lambrecht, B.N. et al. (1999) Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. European Journal of Immunology 29, 3815-38253.0.CO;2-#>CrossRef Google Scholar PubMed

94Weinstock, J.V. et al. (1988) Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P. Journal of Immunology 141, 961-966CrossRef Google Scholar PubMed

95O'Connor, T.M. et al. (2004) The role of substance P in inflammatory disease. Journal of Cellular Physiology 201, 167-180CrossRef Google Scholar PubMed

96Schratzberger, P. et al. (1997) Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. Journal of Immunology 158, 3895-3901CrossRef Google Scholar PubMed

97Delgado, A.V., McManus, A.T. and Chambers, J.P. (2003) Production of tumor necrosis factor-alpha, interleukin 1-beta, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides 37, 355-361CrossRef Google Scholar PubMed

98Matis, W.L., Lavker, R.M. and Murphy, G.F. (1990) Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium. Journal of Investigative Dermatology 94, 492-495CrossRef Google Scholar PubMed

99Vishwanath, R. and Mukherjee, R. (1996) Substance P promotes lymphocyte-endothelial cell adhesion preferentially via LFA-1/ICAM-1 interactions. Journal of Neuroimmunology 71, 163-171CrossRef Google Scholar PubMed

100Quinlan, K.L. et al. (1999) Substance P activates coincident NF-AT- and NF-kappa B-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization. Journal of Immunology 163, 5656-5665CrossRef Google Scholar PubMed

101Bulut, K. et al. (2008) Sensory neuropeptides and epithelial cell restitution: the relevance of SP- and CGRP-stimulated mast cells. International Journal of Colorectal Disease 23, 535-541CrossRef Google Scholar PubMed

102Felderbauer, P. et al. (2007) Substance P induces intestinal wound healing via fibroblasts–evidence for a TGF-beta-dependent effect. International Journal of Colorectal Disease 22, 1475-1480CrossRef Google Scholar PubMed

103Seegers, H.C. et al. (2003) Enhancement of angiogenesis by endogenous substance P release and neurokinin-1 receptors during neurogenic inflammation. Journal of Pharmacology and Experimental Therapeutics 306, 8-12CrossRef Google Scholar PubMed

104Burssens, P. et al. (2005) Exogenously administered substance P and neutral endopeptidase inhibitors stimulate fibroblast proliferation, angiogenesis and collagen organization during Achilles tendon healing. Foot and Ankle International 26, 832-839CrossRef Google Scholar PubMed

105Gibran, N.S. et al. (2002) Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. Journal of Surgical Research 108, 122-128CrossRef Google Scholar

106Blomqvist, A.G. and Herzog, H. (1997) Y-receptor subtypes–how many more? Trends in Neurosciences 20, 294-298CrossRef Google Scholar PubMed

107Ericsson, A. et al. (1987) Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice. Proceedings of the National Academy of Sciences of the United States of America 84, 5585-5589CrossRef Google Scholar PubMed

108Strand, F.L. (1999) Neuropeptides: Regulators of Physiological Processes, MIT Press, Cambridge, MA, USAGoogle Scholar

109Larhammar, D. (1996) Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regulatory Peptides 65, 165-174CrossRef Google Scholar PubMed

110Franco-Cereceda, A., Lundberg, J.M. and Dahlof, C. (1985) Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone. Acta Physiologica Scandinavica 124, 361-369CrossRef Google Scholar PubMed

111Erlinge, D., Brunkwall, J. and Edvinsson, L. (1994) Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP. Regulatory Peptides 50, 259-265CrossRef Google Scholar PubMed

112Zukowska-Grojec, Z. et al. (1993) Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides 14, 263-268CrossRef Google Scholar PubMed

113Frankish, H.M. et al. (1995) Neuropeptide Y, the hypothalamus, and diabetes: insights into the central control of metabolism. Peptides 16, 757-771CrossRef Google Scholar PubMed

114Ahlborg, G. and Lundberg, J.M. (1996) Exercise-induced changes in neuropeptide Y, noradrenaline and endothelin-1 levels in young people with type I diabetes. Clinical Physiology 16, 645-655CrossRef Google Scholar PubMed

115Wallengren, J. et al. (1995) Innervation of the skin of the forearm in diabetic patients: relation to nerve function. Acta Dermato-Venereologica 75, 37-42CrossRef Google Scholar PubMed

116Levy, D.M. et al. (1989) Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: an immunocytochemical study. Diabetologia 32, 427-433CrossRef Google Scholar PubMed

117Kuncova, J. et al. (2005) Heterogenous changes in neuropeptide Y, norepinephrine and epinephrine concentrations in the hearts of diabetic rats. Autonomic Neuroscience 121, 7-15CrossRef Google Scholar PubMed

118Andersson, D. et al. (1992) Diminished contractile responses to neuropeptide Y of arteries from diabetic rabbits. Journal of the Autonomic Nervous System 37, 215-222CrossRef Google Scholar PubMed

119Wheway, J., Herzog, H. and Mackay, F. (2007) NPY and receptors in immune and inflammatory diseases. Current Topics in Medicinal Chemistry 7, 1743-1752CrossRef Google Scholar PubMed

120Groneberg, D.A. et al. (2004) Neuropeptide Y (NPY). Pulmonary Pharmacology and Therapeutics 17, 173-180CrossRef Google Scholar PubMed

121Bedoui, S. et al. (2003) Relevance of neuropeptide Y for the neuroimmune crosstalk. Journal of Neuroimmunology 134, 1-11CrossRef Google Scholar PubMed

122Salo, P. et al. (2007) Neuropeptides regulate expression of matrix molecule, growth factor and inflammatory mediator mRNA in explants of normal and healing medial collateral ligament. Regulatory Peptides 142, 1-6CrossRef Google Scholar PubMed

123Ghersi, G. et al. (2001) Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides 22, 453-458CrossRef Google Scholar PubMed

124Marion-Audibert, A.M. et al. (2000) [Effects of endocrine peptides on proliferation, migration and differentiation of human endothelial cells.] Gastroenterologie Clinique et Biologique 24, 644-648 [Article in French]Google Scholar PubMed

125Zukowska-Grojec, Z. et al. (1998) Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circulation Research 83, 187-195CrossRef Google Scholar PubMed

126Kitlinska, J. et al. (2005) Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Research 65, 1719-1728CrossRef Google Scholar PubMed

127Zukowska, Z. et al. (2003) Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? Canadian Journal of Physiology and Pharmacology 81, 89-94CrossRef Google Scholar PubMed

128Kitlinska, J. et al. (2002) Neuropeptide Y-induced angiogenesis in aging. Peptides 23, 71-77CrossRef Google Scholar PubMed

129van Rossum, D., Hanisch, U.K. and Quirion, R. (1997) Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neuroscience and Biobehavioral Reviews 21, 649-678CrossRef Google Scholar PubMed

130Holzer, P. (1988) Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24, 739-768CrossRef Google Scholar PubMed

131Maggi, C.A. (1995) Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Progress in Neurobiology 45, 1-98CrossRef Google Scholar PubMed

132Russwurm, S. et al. (2001) Procalcitonin and CGRP-1 mrna expression in various human tissues. Shock 16, 109-112CrossRef Google Scholar PubMed

133Hay, D.L., Poyner, D.R. and Quirion, R. (2008) International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor. Pharmacological Reviews 60, 143-145CrossRef Google Scholar PubMed

134Song, J.X. et al. (2008) Impaired transient receptor potential vanilloid 1 in streptozotocin-induced diabetic hearts. International Journal of Cardiology Mar 29; [Epub ahead of print]Google Scholar PubMed

135Dux, M. et al. (2007) Loss of capsaicin-induced meningeal neurogenic sensory vasodilatation in diabetic rats. Neuroscience 150, 194-201CrossRef Google Scholar PubMed

136Adeghate, E. et al. (2006) Pattern of distribution of calcitonin gene-related Peptide in the dorsal root ganglion of animal models of diabetes mellitus. Annals of the New York Academy of Sciences 1084, 296-303CrossRef Google Scholar PubMed

137Oltman, C.L. et al. (2008) Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverse. Diabetes, Obesity and Metabolism 10, 64-74CrossRef Google Scholar PubMed

138Oltman, C.L. et al. (2008) Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction. Diabetes, Obesity and Metabolism Jun 16; [Epub ahead of print]CrossRef Google Scholar

139Sheykhzade, M. et al. (2000) The effect of long-term streptozotocin-induced diabetes on contractile and relaxation responses of coronary arteries: selective attenuation of CGRP-induced relaxations. British Journal of Pharmacology 129, 1212-1218CrossRef Google Scholar PubMed

140Chottova Dvorakova, M. et al. (2005) Cardiomyopathy in streptozotocin-induced diabetes involves intra-axonal accumulation of calcitonin gene-related peptide and altered expression of its receptor in rats. Neuroscience 134, 51-58CrossRef Google Scholar PubMed

141Yorek, M.A. et al. (2004) Sensory nerve innervation of epineurial arterioles of the sciatic nerve containing calcitonin gene-related peptide: effect of streptozotocin-induced diabetes. Experimental Diabesity Research 5, 187-193CrossRef Google Scholar PubMed

142Ambalavanar, R. et al. (2006) Muscle inflammation induces a rapid increase in calcitonin gene-related peptide (CGRP) mRNA that temporally relates to CGRP immunoreactivity and nociceptive behavior. Neuroscience 143, 875-884CrossRef Google Scholar PubMed

143Ambalavanar, R. et al. (2006) Deep tissue inflammation upregulates neuropeptides and evokes nociceptive behaviors which are modulated by a neuropeptide antagonist. Pain 120, 53-68CrossRef Google Scholar PubMed

144Hu, C.L., Xiang, J.Z. and Hu, F.F. (2008) Vanilloid receptor TRPV1, sensory C-fibers, and activation of adventitial mast cells A novel mechanism involved in adventitial inflammation. Medical Hypotheses 71, 102-103CrossRef Google Scholar PubMed

145Linscheid, P. et al. (2004) Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Critical Care Medicine 32, 1715-1721CrossRef Google Scholar PubMed

146Linscheid, P. et al. (2005) Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology 146, 2699-2708CrossRef Google Scholar PubMed

147Dallos, A. et al. (2006) Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Neuropeptides 40, 251-263CrossRef Google Scholar PubMed

148Wang, F. et al. (1992) Calcitonin gene-related peptide inhibits interleukin 2 production by murine T lymphocytes. Journal of Biological Chemistry 267, 21052-21057CrossRef Google Scholar PubMed

149Foster, C.A. et al. (1992) Calcitonin gene-related peptide is chemotactic for human T lymphocytes. Annals of the New York Academy of Sciences 657, 397-404CrossRef Google Scholar PubMed

150Zhang, J.S. et al. (2006) Regulatory peptides modulate adhesion of polymorphonuclear leukocytes to bronchial epithelial cells through regulation of interleukins, ICAM-1 and NF-kappaB/IkappaB. Acta Biochimica et Biophysica Sinica 38, 119-128CrossRef Google Scholar PubMed

151Tran, M.T. et al. (2000) Calcitonin gene-related peptide induces IL-8 synthesis in human corneal epithelial cells. Journal of Immunology 164, 4307-4312CrossRef Google Scholar PubMed

152Yamaguchi, M. et al. (2004) Neuropeptides stimulate production of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha in human dental pulp cells. Inflammation Research 53, 199-204CrossRef Google Scholar PubMed

153Yaraee, R. et al. (2003) Neuropeptides (SP and CGRP) augment pro-inflammatory cytokine production in HSV-infected macrophages. International Immunopharmacology 3, 1883-1887CrossRef Google Scholar PubMed

154Toda, M. et al. (2008) Roles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis. Biomedicine and Pharmacotherapy 62, 352-359CrossRef Google Scholar PubMed

155Haegerstrand, A. et al. (1990) Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 87, 3299-3303CrossRef Google Scholar PubMed

156Richard, D., Huang, Q. and Timofeeva, E. (2000) The corticotropin-releasing hormone system in the regulation of energy balance in obesity. International Journal of Obesity and Related Metabolic Disorders 24 Suppl 2, S36-39CrossRef Google Scholar PubMed

157Baigent, S.M. (2001) Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides 22, 809-820CrossRef Google Scholar PubMed

158Carlin, K.M., Vale, W.W. and Bale, T.L. (2006) Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis. Proceedings of the National Academy of Sciences of the United States of America 103, 3462-3467CrossRef Google Scholar PubMed

159Perrin, M.H. and Vale, W.W. (1999) Corticotropin releasing factor receptors and their ligand family. Annals of the New York Academy of Sciences 885, 312-328CrossRef Google Scholar PubMed

160Chiodini, I. et al. (2005) Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. European Journal of Endocrinology 153, 837-844CrossRef Google Scholar PubMed

161Ghizzoni, L. et al. (1993) Adrenal steroid and adrenocorticotropin responses to human corticotropin-releasing hormone stimulation test in adolescents with type I diabetes mellitus. Metabolism 42, 1141-1145CrossRef Google Scholar PubMed

162Roy, M.S. et al. (1993) The ovine corticotropin-releasing hormone-stimulation test in type I diabetic patients and controls: suggestion of mild chronic hypercortisolism. Metabolism 42, 696-700CrossRef Google Scholar PubMed

163Chan, O. et al. (2002) Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity. Endocrinology 143, 1761-1768CrossRef Google Scholar PubMed

164Chan, O. et al. (2005) Hyperglycemia does not increase basal hypothalamo-pituitary-adrenal activity in diabetes but it does impair the HPA response to insulin-induced hypoglycemia. American Journal of Physiology – Regulatory, Integrative and Comparative Physiology 289, R235-246CrossRef Google Scholar

165Chan, O. et al. (2002) Diabetes impairs hypothalamo-pituitary-adrenal (HPA) responses to hypoglycemia, and insulin treatment normalizes HPA but not epinephrine responses. Diabetes 51, 1681-1689CrossRef Google Scholar

166Turnbull, A.V. and Rivier, C.L. (1999) Sprague-Dawley rats obtained from different vendors exhibit distinct adrenocorticotropin responses to inflammatory stimuli. Neuroendocrinology 70, 186-195CrossRef Google Scholar PubMed

167Lozovaya, N. and Miller, A.D. (2003) Chemical neuroimmunology: health in a nutshell bidirectional communication between immune and stress (limbic-hypothalamic-pituitary-adrenal) systems. Chembiochem 4, 466-484CrossRef Google Scholar

168Chrousos, G.P. (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New England Journal of Medicine 332, 1351-1362CrossRef Google Scholar PubMed

169Elenkov, I.J. et al. (1999) Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Annals of the New York Academy of Sciences 876, 1-11; discussion 11–13CrossRef Google Scholar PubMed

170Elenkov, I.J. and Chrousos, G.P. (1999) Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease. Trends in Endocrinology and Metabolism 10, 359-368CrossRef Google Scholar PubMed

171Webster, E.L., Elenkov, I.J. and Chrousos, G.P. (1997) Corticotropin-releasing hormone acts on immune cells to elicit pro-inflammatory responses. Molecular Psychiatry 2, 345-346CrossRef Google Scholar PubMed

172Monney, L. et al. (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415, 536-541CrossRef Google Scholar PubMed

173Brown, D.H. and Zwilling, B.S. (1994) Activation of the hypothalamic-pituitary-adrenal axis differentially affects the anti-mycobacterial activity of macrophages from BCG-resistant and susceptible mice. Journal of Neuroimmunology 53, 181-187CrossRef Google Scholar PubMed

174Sheridan, J.F. et al. (1998) Stress-induced neuroendocrine modulation of viral pathogenesis and immunity. Annals of the New York Academy of Sciences 840, 803-808CrossRef Google Scholar PubMed

175Webster, E.L. et al. (1998) Corticotropin-releasing hormone and inflammation. Annals of the New York Academy of Sciences 840, 21-32CrossRef Google Scholar PubMed

176Karalis, K. et al. (1997) CRH and the immune system. Journal of Neuroimmunology 72, 131-136CrossRef Google Scholar PubMed

177Theoharides, T.C. et al. (1998) Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139, 403-413CrossRef Google Scholar PubMed

178Karalis, K. et al. (1991) Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254, 421-423CrossRef Google Scholar PubMed

179Crofford, L.J. et al. (1993) Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. Journal of Immunology 151, 1587-1596CrossRef Google Scholar PubMed

180Glasper, E.R. and Devries, A.C. (2005) Social structure influences effects of pair-housing on wound healing. Brain, Behavior, and Immunity 19, 61-68CrossRef Google Scholar PubMed

181Detillion, C.E. et al. (2004) Social facilitation of wound healing. Psychoneuroendocrinology 29, 1004-1011CrossRef Google Scholar PubMed

182Kalin, N.H. et al. (2006) Stress decreases, while central nucleus amygdala lesions increase, IL-8 and MIP-1alpha gene expression during tissue healing in non-human primates. Brain, Behavior, and Immunity 20, 564-568CrossRef Google Scholar PubMed

183Head, C.C. et al. (2006) Androstenediol reduces the anti-inflammatory effects of restraint stress during wound healing. Brain, Behavior, and Immunity 20, 590-596CrossRef Google Scholar PubMed

184Mercado, A.M. et al. (2002) Altered kinetics of IL-1 alpha, IL-1 beta, and KGF-1 gene expression in early wounds of restrained mice. Brain, Behavior, and Immunity 16, 150-162CrossRef Google Scholar PubMed

185Rojas, I.G. et al. (2002) Stress-induced susceptibility to bacterial infection during cutaneous wound healing. Brain, Behavior, and Immunity 16, 74-84CrossRef Google Scholar PubMed

186Gantz, I. and Fong, T.M. (2003) The melanocortin system. American Journal of Physiology – Endocrinology and Metabolism 284, E468-474CrossRef Google Scholar PubMed

187Seidah, N.G. et al. (1999) The subtilisin/kexin family of precursor convertases. Emphasis on PC1, PC2/7B2, POMC and the novel enzyme SKI-1. Annals of the New York Academy of Sciences 885, 57-74CrossRef Google Scholar PubMed

188Thody, A.J. et al. (1983) MSH peptides are present in mammalian skin. Peptides 4, 813-816CrossRef Google Scholar PubMed

189Slominski, A. et al. (1993) Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. Journal of Laboratory and Clinical Medicine 122, 658-666Google Scholar PubMed

190Mazurkiewicz, J.E., Corliss, D. and Slominski, A. (2000) Spatiotemporal expression, distribution, and processing of POMC and POMC-derived peptides in murine skin. Journal of Histochemistry and Cytochemistry 48, 905-914CrossRef Google Scholar PubMed

191Bohm, M. et al. (2006) Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. Journal of Investigative Dermatology 126, 1966-1975CrossRef Google Scholar PubMed

192Bhardwaj, R. et al. (1997) Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 on human monocytes. Journal of Immunology 158, 3378-3384CrossRef Google Scholar PubMed

193Hochgeschwender, U. et al. (2003) Altered glucose homeostasis in proopiomelanocortin-null mouse mutants lacking central and peripheral melanocortin. Endocrinology 144, 5194-5202CrossRef Google Scholar PubMed

194Fan, W. et al. (2000) The central melanocortin system can directly regulate serum insulin levels. Endocrinology 141, 3072-3079CrossRef Google Scholar PubMed

195Lee, M. et al. (2007) Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet. American Journal of Physiology – Endocrinology and Metabolism 293, E121-131CrossRef Google Scholar PubMed

196Kim, E.M. et al. (1999) STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats. American Journal of Physiology 276, R1320-1326Google Scholar PubMed

197Havel, P.J. et al. (2000) Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes 49, 244-252CrossRef Google Scholar PubMed

198Abou-Mohamed, G. et al. (1995) HP-228, a novel synthetic peptide, inhibits the induction of nitric oxide synthase in vivo but not in vitro. Journal of Pharmacology and Experimental Therapeutics 275, 584-591Google Scholar

199Rajora, N. et al. (1997) alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation. Journal of Neuroscience 17, 2181-2186CrossRef Google Scholar PubMed

200Rajora, N. et al. (1997) alpha-MSH modulates experimental inflammatory bowel disease. Peptides 18, 381-385CrossRef Google Scholar PubMed

201Catania, A. et al. (1999) alpha-MSH in systemic inflammation. Central and peripheral actions. Annals of the New York Academy of Sciences 885, 183-187CrossRef Google Scholar PubMed

202Gatti, S. et al. (2002) alpha-Melanocyte-stimulating hormone protects the allograft in experimental heart transplantation. Transplantation 74, 1678-1684CrossRef Google Scholar PubMed

203Catania, A. et al. (2004) Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacological Reviews 56, 1-29CrossRef Google Scholar PubMed

204Bohm, M. et al. (1999) Alpha-melanocyte-stimulating hormone modulates activation of NF-kappa B and AP-1 and secretion of interleukin-8 in human dermal fibroblasts. Annals of the New York Academy of Sciences 885, 277-286CrossRef Google Scholar PubMed

205Bhardwaj, R.S. et al. (1996) Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. Journal of Immunology 156, 2517-2521CrossRef Google Scholar PubMed

206Taherzadeh, S. et al. (1999) alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte/macrophages. American Journal of Physiology 276, R1289-1294Google Scholar PubMed

207Catania, A. et al. (2000) Plasma concentrations and anti-L-cytokine effects of alpha-melanocyte stimulating hormone in septic patients. Critical Care Medicine 28, 1403-1407CrossRef Google Scholar PubMed

208Star, R.A. et al. (1995) Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proceedings of the National Academy of Sciences of the United States of America 92, 8016-8020CrossRef Google Scholar PubMed

209Mandrika, I., Muceniece, R. and Wikberg, J.E. (2001) Effects of melanocortin peptides on lipopolysaccharide/interferon-gamma-induced NF-kappaB DNA binding and nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanisms of action. Biochemical Pharmacology 61, 613-621CrossRef Google Scholar PubMed

210Kalden, D.H. et al. (1999) Mechanisms of the antiinflammatory effects of alpha-MSH. Role of transcription factor NF-kappa B and adhesion molecule expression. Annals of the New York Academy of Sciences 885, 254-261CrossRef Google Scholar PubMed

211Hartmeyer, M. et al. (1997) Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone. Journal of Immunology 159, 1930-1937CrossRef Google Scholar PubMed

212Redondo, P. et al. (1998) Alpha-MSH regulates interleukin-10 expression by human keratinocytes. Archives of Dermatological Research 290, 425-428CrossRef Google Scholar PubMed

213Bonfiglio, V. et al. (2006) Effects of the COOH-terminal tripeptide alpha-MSH(11–13) on corneal epithelial wound healing: role of nitric oxide. Experimental Eye Research 83, 1366-1372CrossRef Google Scholar PubMed

214Evers, B.M. (2006) Neurotensin and growth of normal and neoplastic tissues. Peptides 27, 2424-2433CrossRef Google Scholar PubMed

215Gross, K.J. and Pothoulakis, C. (2007) Role of neuropeptides in inflammatory bowel disease. Inflammatory Bowel Diseases 13, 918-932CrossRef Google Scholar PubMed

216St-Gelais, F., Jomphe, C. and Trudeau, L.E. (2006) The role of neurotensin in central nervous system pathophysiology: what is the evidence? Journal of Psychiatry and Neuroscience 31, 229-245Google Scholar PubMed

217Sheppard, M.C. et al. (1985) Immunoreactive neurotensin in spontaneous syndromes of obesity and diabetes in mice. Acta Endocrinologica 108, 532-536Google Scholar PubMed

218Berelowitz, M. and Frohman, L.A. (1982) The role of neurotensin in the regulation of carbohydrate metabolism and in diabetes. Annals of the New York Academy of Sciences 400, 150-159CrossRef Google Scholar PubMed

219Fernstrom, M.H. et al. (1981) Immunoreactive neurotensin levels in pancreas: elevation in diabetic rats and mice. Metabolism 30, 853-855CrossRef Google Scholar PubMed

220El-Salhy, M. (1998) Neuroendocrine peptides of the gastrointestinal tract of an animal model of human type 2 diabetes mellitus. Acta Diabetologica 35, 194-198CrossRef Google Scholar PubMed

221Service, F.J. et al. (1986) Neurotensin in diabetes and obesity. Regulatory Peptides 14, 85-92CrossRef Google Scholar PubMed

222Goldman, R. et al. (1982) Enhancement of phagocytosis by neurotensin, a newly found biological activity of the neuropeptide. Advances in Experimental Medicine and Biology 155, 133-141CrossRef Google Scholar PubMed

223Koff, W.C. and Dunegan, M.A. (1985) Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. Journal of Immunology 135, 350-354CrossRef Google Scholar PubMed

224Lemaire, I. (1988) Neurotensin enhances IL-1 production by activated alveolar macrophages. Journal of Immunology 140, 2983-2988CrossRef Google Scholar PubMed

225Garrido, J.J. et al. (1992) Modulation by neurotensin and neuromedin N of adherence and chemotaxis capacity of murine lymphocytes. Regulatory Peptides 41, 27-37Google Scholar PubMed

226Evers, B.M. et al. (1994) Characterization of functional neurotensin receptors on human lymphocytes. Surgery 116, 134-139; discussion 139–140Google Scholar PubMed

227Hartschuh, W., Weihe, E. and Reinecke, M. (1983) Peptidergic (neurotensin, VIP, substance P) nerve fibres in the skin. Immunohistochemical evidence of an involvement of neuropeptides in nociception, pruritus and inflammation. British Journal of Dermatology 109 Suppl 25, 14-17CrossRef Google Scholar PubMed

228Donelan, J. et al. (2006) Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proceedings of the National Academy of Sciences of the United States of America 103, 7759-7764CrossRef Google Scholar PubMed

229Zhao, D. et al. (2005) Neurotensin stimulates interleukin-8 expression through modulation of I kappa B alpha phosphorylation and p65 transcriptional activity: involvement of protein kinase C alpha. Molecular Pharmacology 67, 2025-2031CrossRef Google Scholar PubMed

230Zhao, D. et al. (2003) Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathways. American Journal of Physiology – Cell Physiology 284, C1397-1404CrossRef Google Scholar PubMed

231Brun, P. et al. (2005) Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation. American Journal of Physiology – Gastrointestinal and Liver Physiology 288, G621-629CrossRef Google Scholar PubMed

232Martin, S., Vincent, J.P. and Mazella, J. (2003) Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. Journal of Neuroscience 23, 1198-1205CrossRef Google Scholar PubMed

233Dinh, T.L. and Veves, A. (2006) Treatment of diabetic ulcers. Dermatologic Therapy 19, 348-355CrossRef Google Scholar PubMed

234Steed, D.L. et al. (2006) Guidelines for the treatment of diabetic ulcers. Wound Repair and Regeneration 14, 680-692CrossRef Google Scholar PubMed

235Pradhan, L., Andersen, N.D., Nabzdyk, C., LoGerfo, F.W. and Veves, A. (2007) Wound healing abnormalities in diabetes and new therapeutic interventions. US Endocrine Disease 2, 68-72CrossRef Google Scholar

236Denet, A.R., Vanbever, R. and Preat, V. (2004) Skin electroporation for transdermal and topical delivery. Advanced Drug Delivery Reviews 56, 659-674CrossRef Google Scholar PubMed

237Vanbever, R. and Preat, V.V. (1999) In vivo efficacy and safety of skin electroporation Advanced Drug Delivery Reviews 35, 77-88CrossRef Google Scholar PubMed

238Lee, P.Y., Chesnoy, S. and Huang, L. (2004) Electroporatic delivery of TGF-beta1 gene works synergistically with electric therapy to enhance diabetic wound healing in db/db mice. Journal of Investigative Dermatology 123, 791-798CrossRef Google Scholar PubMed

239Lin, M.P. et al. (2006) Delivery of plasmid DNA expression vector for keratinocyte growth factor-1 using electroporation to improve cutaneous wound healing in a septic rat model. Wound Repair and Regeneration 14, 618-624CrossRef Google Scholar

240Gohshi, A. et al. (1998) Changes in adrenocorticotropic hormone (ACTH) release from the cultured anterior pituitary cells of streptozotocin-induced diabetic rats. Biological & Pharmaceutical Bulletin 21, 795-799CrossRef Google Scholar PubMed

Article contents

Inflammation and neuropeptides: the connection in diabetic wound healing

Abstract

Access options

Article purchase

Temporarily unavailable

References

References

Further reading, resources and contacts

This article has been cited by the following publications. This list is generated based on data provided by Crossref.

Article contents

Inflammation and neuropeptides: the connection in diabetic wound healing

Abstract

Access options

Article purchase

Temporarily unavailable

References

References

Further reading, resources and contacts

Save article to Kindle

Save article to Dropbox

Save article to Google Drive

Reply to: Submit a response

Your details

You have entered the maximum number of contributors

Conflicting interests